- Home
- NMRA vs NMT Comparison
NMRA vs NMT Comparison
Compare NMRA & NMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- NMT
- Stock Information
- Founded
- NMRA 2019
- NMT 1993
- Country
- NMRA United States
- NMT United States
- Employees
- NMRA N/A
- NMT N/A
- Industry
- NMRA
- NMT Finance/Investors Services
- Sector
- NMRA
- NMT Finance
- Exchange
- NMRA Nasdaq
- NMT Nasdaq
- Market Cap
- NMRA 112.8M
- NMT 110.6M
- IPO Year
- NMRA 2023
- NMT N/A
- Fundamental
- Price
- NMRA $0.73
- NMT $12.05
- Analyst Decision
- NMRA Buy
- NMT
- Analyst Count
- NMRA 8
- NMT 0
- Target Price
- NMRA $9.29
- NMT N/A
- AVG Volume (30 Days)
- NMRA 846.2K
- NMT 19.1K
- Earning Date
- NMRA 05-12-2025
- NMT 01-01-0001
- Dividend Yield
- NMRA N/A
- NMT 3.21%
- EPS Growth
- NMRA N/A
- NMT N/A
- EPS
- NMRA N/A
- NMT N/A
- Revenue
- NMRA N/A
- NMT N/A
- Revenue This Year
- NMRA N/A
- NMT N/A
- Revenue Next Year
- NMRA N/A
- NMT N/A
- P/E Ratio
- NMRA N/A
- NMT N/A
- Revenue Growth
- NMRA N/A
- NMT N/A
- 52 Week Low
- NMRA $0.61
- NMT $9.05
- 52 Week High
- NMRA $17.19
- NMT $10.93
- Technical
- Relative Strength Index (RSI)
- NMRA 45.93
- NMT 63.31
- Support Level
- NMRA $0.66
- NMT $11.91
- Resistance Level
- NMRA $0.73
- NMT $12.33
- Average True Range (ATR)
- NMRA 0.06
- NMT 0.20
- MACD
- NMRA 0.01
- NMT 0.02
- Stochastic Oscillator
- NMRA 59.70
- NMT 69.01
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About NMT Nuveen Massachusetts Quality Municipal Income Fund
Nuveen Massachusetts Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's objective seeks to provide current income exempt from both regular federal and Massachusetts income taxes by investing in a portfolio of municipal obligations issued by state and local government authorities within a single state or certain U.S. territories.